Literature DB >> 23667762

Is the completion time of a questionnaire a pivotal factor when proving feasibility?

Jung Ho Park1.   

Abstract

Entities:  

Year:  2013        PMID: 23667762      PMCID: PMC3644667          DOI: 10.5056/jnm.2013.19.2.267

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


× No keyword cloud information.
TO THE EDITOR: With great interest, I read Dr. Nonaka's,1 "Comparative study of 2 different questionnaires in Japanese patients: the quality of life and utility evaluation survey technology questionnaire (QUEST) versus the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FSSG)." I totally agree the miscomprehensions due to the difficulty of the questions are important reasons why several questionnaires have not been widely used in clinical settings. Furthermore, the complexity of questionnaires could be more problematic to old patients as a result of the age-related declines in cognitive functions.2 Considering Korea's rapidly aging population, easier questionnaire would be more useful in clinical setting if no difference exists in the sensitivity, specificity and accuracy between questionnaires. Prior to the use in clinical trials, questionnaires need to be tested for validation of three characteristics: reliability, validity and responsiveness.3,4 Reliability is defined by the extent to which a questionnaire produces the same results for each repeated trial. Validity refers to whether the questionnaire meets its expected function or role in a trial. Finally, responsiveness describes whether the questionnaire is capable of detecting changes in a condition over time, which might reflect therapeutic effects.5 Another important characteristic of any measurement procedure is feasibility. When evaluating the feasibility of a questionnaire, questionnaires regarding the patients' preferences were evaluated by calculating the satisfaction rate,6 or the number of times each patient consulted aid from the assessing investigators.7 The study by Nonaka et al1 lucidly indicated that the completion time of a questionnaire is a pivotal factor when proving feasibility, revealing that the FSSG questionnaire was easier for the Japanese patients to complete than that from QUEST. In fact, it is important to make a questionnaire brief and easy for patients. However, time-efficiency is just one of the important factors in the feasibility study. Other factors such as the patients' satisfaction and response rate should be taken into account as well. And also, shorter completion time on the FSSG could be caused by asking different type of questions, instead of complexity of questions. Other limitations of the study by Nonaka et al1 may include a relatively small sample size and wide age distribution of enrolled subjects. A group of older people may require more completion time than it would take with younger group. Nevertheless, the study by Nonaka et al1 has a strong point that it is the first to evaluate feasibility by calculating completion time of the questionnaire.
  7 in total

Review 1.  Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?

Authors:  R T Bartus
Journal:  J Am Geriatr Soc       Date:  1990-06       Impact factor: 5.562

Review 2.  Evaluating patient-based outcome measures for use in clinical trials.

Authors:  R Fitzpatrick; C Davey; M J Buxton; D R Jones
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

3.  Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

Authors:  S J Veldhuyzen van Zanten; C Cleary; N J Talley; T C Peterson; O Nyrén; L A Bradley; M Verlinden; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

Review 4.  Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review.

Authors:  Adam Fraser; Brendan Delaney; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

5.  Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale.

Authors:  H W van Marwijk; P Wallace; G H de Bock; J Hermans; A A Kaptein; J D Mulder
Journal:  Br J Gen Pract       Date:  1995-04       Impact factor: 5.386

6.  Comparative Study of 2 Different Questionnaires in Japanese Patients: The Quality of Life and Utility Evaluation Survey Technology Questionnaire (QUEST) Versus the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease Questionnaire (FSSG).

Authors:  Takashi Nonaka; Takaomi Kessoku; Yuji Ogawa; Shogo Yanagisawa; Tadahiko Shiba; Takashi Sakaguchi; Kazuhiro Atsukawa; Hisao Takahashi; Yusuke Sekino; Hiroshi Iida; Hiroki Endo; Yasunari Sakamoto; Tomoko Koide; Hirokazu Takahashi; Masato Yoneda; Shin Maeda; Atsushi Nakajima; Eiji Gotoh; Masahiko Inamori
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

7.  Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease.

Authors:  V Velanovich
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

  7 in total
  1 in total

1.  Is the Completion Time of a Questionnaire a Pivotal Factor When Proving Feasibility?: Author's Reply.

Authors:  Takashi Nonaka; Masahiko Inamori
Journal:  J Neurogastroenterol Motil       Date:  2013-04       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.